Table 1. Estimated total nut1 intake and pancreatic ductal adenocarcinoma cases by country in the EPIC cohort.
| Country | Cohort sample n | Person-years | Total PDAC cases n (%)2 | Male PDAC cases n (%)2 | Female PDAC cases n (%)2 | Microscopically confirmed cases | Consumers of total nuts | Total nuts among consumers (g/day) | |
|---|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | Median (p25–p75) | Mean ± SD | ||||||
| France | 67,403 | 869,372 | 56 (4.4) | 56 (7.7) | 26 (2.9) | 48,381 (71.8) | 4.8 (2.1–8.6) | 7.7 ± 9.0 | |
| Italy | 44,545 | 630,951 | 104 (8.1) | 35 (6.3) | 69 (9.5) | 66 (7.3) | 39,667 (89.0) | 0.2 (0.2–1.0) | 1.0 ± 2.1 |
| Spain | 39,989 | 637,947 | 106 (8.3) | 55 (9.9) | 51 (7.0) | 80 (8.8) | 15,200 (38.8) | 5.9 (2.1–13.7) | 11.3 ± 15.6 |
| United Kingdom | 75,416 | 1,122,765 | 188 (14.7) | 69 (12.4) | 119 (16.4) | 19 (2.1) | 63,134 (83.7) | 2.3 (0.5–7.0) | 7.1 ± 12.3 |
| The Netherlands | 36,539 | 524,671 | 93 (7.3) | 20 (3.6) | 73 (10.0) | 67 (87.4) | 34,402 (94.2) | 5.0 (1.8–11.9) | 9.3 ± 12.8 |
| Greece | 26,048 | 281,284 | 44 (3.4) | 25 (4.5) | 19 (2.6) | 18 (2.0) | 24,173 (92.8) | 5.3 (0.2–8.0) | 6.3 ± 8.5 |
| Germany | 48,557 | 504,479 | 116 (9.0) | 72 (13.0) | 44 (6.1) | 88 (9.7) | 43,597 (89.9) | 1.5 (0.6–3.7) | 3.9 ± 7.7 |
| Sweden | 48,674 | 801,130 | 204 (15.9) | 93 (16.7) | 111 (15.3) | 197 (21.6) | 30,489 (62.6) | 0.3 (0.0–0.8) | 1.5 ± 4.2 |
| Denmark | 55,014 | 815,097 | 325 (25.3) | 187(33.6) | 138 (19.0) | 303 (33.3) | 40,815 (74.2) | 0.8 (0.8–1.6) | 2.4 ± 4.5 |
| Norway | 33,975 | 452,171 | 47 (3.7) | 47 (6.5) | 46 (5.10) | 16,105 (47.4) | 3.0 (3.0–6.4) | 4.6 ± 3.9 | |
| Total | 476,160 | 6,639,867 | 1,283 (100) | 556 (100) | 727 (100) | 910 (100) | 355,963 (74.8) | 2.3 (0.7–5.7) | 5.3 ± 9.5 |
1
Total nut intake is the sum of the total intake of nuts and seeds.
2
Percentages are calculated by country.
Abbreviations: EPIC, European Prospective Investigation into Cancer and Nutrition; PDAC, pancreatic ductal adenocarcinoma; SD, standard deviation.